![Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in a Cohort of Individuals with Personal and/or Family History of Breast Cancer[v1] | Preprints Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in a Cohort of Individuals with Personal and/or Family History of Breast Cancer[v1] | Preprints](https://www.preprints.org/img/dyn_abstract_figures/2021/05/f4c067daf16fcfeec855a843effdaabf/preprints-42714-graphical.v1.jpg)
Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in a Cohort of Individuals with Personal and/or Family History of Breast Cancer[v1] | Preprints
![Ioannis CHRISTODOULOU | Post-doctoral fellow | BSc, MSc, DIC, PhD, AdvCert | National Hellenic Research Foundation, Athens | EIE | Institute of Biology, Medicinal Chemistry and Biotechnology Ioannis CHRISTODOULOU | Post-doctoral fellow | BSc, MSc, DIC, PhD, AdvCert | National Hellenic Research Foundation, Athens | EIE | Institute of Biology, Medicinal Chemistry and Biotechnology](https://i1.rgstatic.net/ii/profile.image/272262112739330-1441923754222_Q128/Ioannis-Christodoulou-2.jpg)
Ioannis CHRISTODOULOU | Post-doctoral fellow | BSc, MSc, DIC, PhD, AdvCert | National Hellenic Research Foundation, Athens | EIE | Institute of Biology, Medicinal Chemistry and Biotechnology
![PDF) Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: Final results of the ATENA lipid substudy PDF) Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: Final results of the ATENA lipid substudy](https://i1.rgstatic.net/publication/26296414_Extended_adjuvant_hormonal_therapy_with_exemestane_has_no_detrimental_effect_on_the_lipid_profile_of_postmenopausal_breast_cancer_patients_Final_results_of_the_ATENA_lipid_substudy/links/09e4150b84cf4ac76e000000/largepreview.png)
PDF) Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: Final results of the ATENA lipid substudy
![Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel - Tung - 2015 - Cancer - Wiley Online Library Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel - Tung - 2015 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/93a87ebb-c65d-4944-b337-c7a6142d20c9/cncr.v121.1.cover.jpg)
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel - Tung - 2015 - Cancer - Wiley Online Library
![E. XEPAPADAKI | Ph.D candidate | Doctor of Philosophy | University of Patras, Pátra | UP | Department of Internal Medicine E. XEPAPADAKI | Ph.D candidate | Doctor of Philosophy | University of Patras, Pátra | UP | Department of Internal Medicine](https://i1.rgstatic.net/ii/profile.image/1009198053728258-1617622974310_Q512/E-Xepapadaki.jpg)
E. XEPAPADAKI | Ph.D candidate | Doctor of Philosophy | University of Patras, Pátra | UP | Department of Internal Medicine
![PDF) MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer PDF) MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer](https://i1.rgstatic.net/publication/303295400_MYC_copy_gain_chromosomal_instability_and_PI3K_activation_as_potential_markers_of_unfavourable_outcome_in_trastuzumab-treated_patients_with_metastatic_breast_cancer/links/5746b97a08aea45ee8561f3b/largepreview.png)